Agenda – Xconomy

Please take note that the venue for this event has moved to the Hyatt Regency San Francisco.

Recent relevant Xconomy coverage:

3 – 4:00pm	Registration & Networking
4 – 4:30pm	Spinal Cord Injury Therapies Step Forward Ethan Perlstein – Chief Scientific Officer, Christopher & Dana Reeve Foundation Abla Creasey – Vice President of Therapeutics and Strategic Infrastructure, California Institute for Regenerative Medicine Explore the cutting-edge research that could become new therapies for spinal cord injuries and other traumatic neurological damage.
4:30 – 5:00pm	AI Makes Headway Finding New Depression Drugs Jane Tiller – Chief Medical Officer, BlackThorn Therapeutics Kristina Burow – Managing Director, ARCH Venture Partners Depression is a particularly challenging area for drug hunters, but BlackThorn Therapeutics says artificial intelligence, brain imaging, and other tools give it an edge finding and developing new medicines.
5 – 5:30pm	An Immunotherapy Approach to Alzheimer’s Stephanie Yonker – Vice President of Legal, Alector Does the immune system hold the key to understanding and treating Alzheimer’s disease? Alector is developing a drug that engages an immune cell in the brain to address neurodegeneration.
5:30 – 6:30pm	Networking Reception Drinks & hors d’oeuvres

Schedule is subject to change.